• LANGUAGE:中文en
product
contact
International trading contact 
/
/
/
[Ornithine Aspartate for Injection]

[Ornithine Aspartate for Injection]

Ornithine Aspartate for Injection is indicated for treatment of patients with high blood ammonia disease caused by acute and chronic liver disease such as cirrhosis, fatty liver, hepatitis, especially for relieving central nervous system symptoms caused by liver disease and hepatic coma.
Retail price
0.0
Market price
0.0
Number of views:
1029
Product serial number
Quantity
-
+
Stock:
1
国药准字:
Ornithine Aspartate for Injection is indicated for treatment of patients with high blood ammonia disease caused by acute and chronic liver disease such as cirrhosis, fatty liver, hepatitis, especially for relieving central nervous system symptoms caused by liver disease and hepatic coma.
 
APPLICATIONS
☆  Acute and chronic viral hepatitis
☆  Severe hepatitis
☆  Liver and gallbladder surgery
☆  Tumor radiotherapy and chemotherapy
☆  Alcoholic liver disease and alcohol poisoning;
☆  Fatty liver;
☆  Drug-induced liver injury
 
PRODUCT'S FEATURES
☆  The only biochemical type of live-protecting new drug approved by CFDA during 1998-2004
☆  Supported by National Key Drug Innovation Program, National Key Product
☆  The only generic manufacturer of Ornithine Aspartate in China
☆  High safety
☆  A necessary drug for the treatment of hepatic encephalopathy and acute hepatic coma
☆  Preferred liver-protecting drug in liver transplant
☆  Comprehensively resolve chemical and biological liver problems, protect and enhance liver functions
☆  With reliable curative effects
 
PACKING
2.5g/vial *10 vials/box
0.5g/vial *10 vials/box
Scan the QR code to read on your phone
We could not find any corresponding parameters, please add them to the properties table
官方客服微信
top